
    
      This is a 12-week, randomized, double-blind, multicenter study comparing the effect of
      naproxcinod and naproxen on 24 hour arterial blood pressure profile. Patients will be
      randomly allocated to different naproxcinod or naproxen doses in a 1:1 ratio.
    
  